To explore how LIF promotes cell migration and invasion in breast cancer, the downstream targets were detected and we found that selective inhibitors or siRNA of Stat3 leads to a decrease in the migration and invasion of breast cancer cells induced by rhLIF or CAAs. Here, LIF is linked to breast carcinoma.